EVOLVING AZIMUTH IN MUSA CONTEXT

Recruiting now · Not applicable

Conditions studied: Heart Failure, Blood Pressure, Weight Change, Telemonitoring

In brief

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Key facts

Study ID

NCT07022067

Run by

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

People needed

184

Starts

2024-10-02

Expected to finish

2025-08-31

Last updated by the study team

2025-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have been diagnosed with chronic CS according to the ESC guidelines;
• Over 18 years of age;
• Patients admitted to hospital or with access to first aid within the last year;
• Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);
• Wi-Fi or 3G coverage at home;
• Ability to give written informed consent.

You may not qualify if…

• Severe psychiatric disorder
• Inability to use portable technologies
• Patients unable to use the equipment provided
• Patients who deny consent to study participation

Where it is running

• Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico — Milan, Italy, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.